
Frequency of occurrence of the JAK2V617F mutation for patients with different variants of Tronic myeloproliferative disorders (CMPD) is observed. Assessment in order to get differentional diagnostics of CMPD with nonproliferative diseases of the blood was evaluated in 79 cases of 128 (that is 61.7%). The cytogenetical research showed that 2 patients of 20 (10%) have clonal chromosome aberrations with poor prognosis.
C целью дифференциальной диагностики хронических миелопролиферативных заболеваний (ХМПЗ) с другими заболеваниями системы крови проведено исследование мутации JAK2V617F и цитогенетическое исследование. Мутация JAK2V617F выявлялась у 79 больных из 128, что составляет 61,7%. При цитогенетическом исследовании у 2 (10%) из 20 больных были обнаружены клональные прогностически неблагоприятные хромосомные аберрации.
ХРОНИЧЕСКОЕ МИЕЛОПРОЛИФЕРАТИВНОЕ ЗАБОЛЕВАНИЕ, JAK2V617F МУТАЦИЯ, ХРОМОСОМНЫЕ АБЕРРАЦИИ
ХРОНИЧЕСКОЕ МИЕЛОПРОЛИФЕРАТИВНОЕ ЗАБОЛЕВАНИЕ, JAK2V617F МУТАЦИЯ, ХРОМОСОМНЫЕ АБЕРРАЦИИ
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
